ES8607320A1 - Cephalosporins - Google Patents
CephalosporinsInfo
- Publication number
- ES8607320A1 ES8607320A1 ES544723A ES544723A ES8607320A1 ES 8607320 A1 ES8607320 A1 ES 8607320A1 ES 544723 A ES544723 A ES 544723A ES 544723 A ES544723 A ES 544723A ES 8607320 A1 ES8607320 A1 ES 8607320A1
- Authority
- ES
- Spain
- Prior art keywords
- group
- formula
- image
- hydrogen atom
- cephalosporins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/18—Oxygen or sulfur atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Cephalosporins of formula < IMAGE > wherein -A- represents a group of the formula, -CH2- or a group of the formula, < IMAGE > in which R<18> represents a hydrogen atom or a substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aralkyl, aryl, heterocyclic group or a hydroxyl-protecting group or a group of the formula, < IMAGE > (each of R<19> and R<20>, which may be the same or different, represents a hydroxyl, alkyl, aralkyl, aryl, alkoxy, aralkyloxy or aryloxy group), and the bond @ means that the compound may be a syn-isomer or an anti-isomer or a mixture thereof R<1> is H or carboxyl-protecting group R<2> is a substituted or unsubstituted 2,3- dioxo-1,2,3,4-tetrahydropyrazinyl, 2-oxo-1,2-dihydropyrazinyl, 3,6-dioxo- 1,2,3,6-tetrahydropyridazinyl or 6-oxo-1,6-dihydropyridazinyl group R<3> is H or alkoxy R<4> represents a hydrogen atom or a halogen atom and R<5> represents a hydrogen atom or a protected or unprotected amino group. These cephalosporins have a broad antibacterial spectrum, are stable against beta -lactamase produced by bacteria, have a low toxicity, and are well absorbed when administered orally or parenterally. Intermediates of formula: < IMAGE > where R<1> to R<3> are as above and R<28> is amino are also disclosed.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57200382A JPS5993085A (en) | 1982-11-17 | 1982-11-17 | Novel cephalosporin compound |
JP58067871A JPS59193893A (en) | 1983-04-19 | 1983-04-19 | Novel cephalosporins |
JP58199945A JPS6092293A (en) | 1983-10-27 | 1983-10-27 | Novel cephalosporin compound |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8607320A1 true ES8607320A1 (en) | 1986-05-16 |
ES544723A0 ES544723A0 (en) | 1986-05-16 |
Family
ID=27299565
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES527333A Expired ES8602815A1 (en) | 1982-11-17 | 1983-11-16 | Cephalosporins |
ES544723A Expired ES8607320A1 (en) | 1982-11-17 | 1985-06-28 | Cephalosporins |
ES544724A Expired ES8607321A1 (en) | 1982-11-17 | 1985-06-28 | Cephalosporins |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES527333A Expired ES8602815A1 (en) | 1982-11-17 | 1983-11-16 | Cephalosporins |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES544724A Expired ES8607321A1 (en) | 1982-11-17 | 1985-06-28 | Cephalosporins |
Country Status (12)
Country | Link |
---|---|
KR (1) | KR870000611B1 (en) |
AU (2) | AU549861B2 (en) |
BE (1) | BE898249A (en) |
CA (2) | CA1253486A (en) |
CH (2) | CH657135A5 (en) |
DE (2) | DE3347928C2 (en) |
DK (1) | DK521883A (en) |
ES (3) | ES8602815A1 (en) |
FI (1) | FI75827C (en) |
FR (1) | FR2536074B1 (en) |
GB (2) | GB2131800B (en) |
NL (1) | NL192792C (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6064986A (en) * | 1983-09-20 | 1985-04-13 | Toyama Chem Co Ltd | Production of cephalosporin |
AT397086B (en) * | 1984-05-25 | 1994-01-25 | Toyama Chemical Co Ltd | Process for the preparation of novel 2-(2-aminothiazol-4- yl)-2-(syn)-alkoxyiminoacetamides |
GB2161476B (en) * | 1984-05-25 | 1988-01-27 | Toyama Chemical Co Ltd | 2-aminothiazolyl-2-methoxyimino acetamides and their use in preparing cephalosporins |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS53119885A (en) * | 1977-03-29 | 1978-10-19 | Takeda Chem Ind Ltd | Cephalosporin derivatives |
DE2714880A1 (en) * | 1977-04-02 | 1978-10-26 | Hoechst Ag | CEPHEMDER DERIVATIVES AND PROCESS FOR THEIR PRODUCTION |
JPS5492986A (en) * | 1977-12-28 | 1979-07-23 | Takeda Chem Ind Ltd | Cephalosporin derivative |
NZ198350A (en) * | 1980-09-25 | 1985-02-28 | Toyama Chemical Co Ltd | Cephalosporins and intermediates;pharmaceutical compositions |
-
1983
- 1983-11-15 DK DK521883A patent/DK521883A/en not_active Application Discontinuation
- 1983-11-15 FI FI834183A patent/FI75827C/en not_active IP Right Cessation
- 1983-11-16 GB GB08330599A patent/GB2131800B/en not_active Expired
- 1983-11-16 GB GB08603333A patent/GB2171697B/en not_active Expired
- 1983-11-16 KR KR1019830005429A patent/KR870000611B1/en not_active IP Right Cessation
- 1983-11-16 ES ES527333A patent/ES8602815A1/en not_active Expired
- 1983-11-16 CH CH6165/83A patent/CH657135A5/en not_active IP Right Cessation
- 1983-11-16 AU AU21429/83A patent/AU549861B2/en not_active Ceased
- 1983-11-16 CA CA000441286A patent/CA1253486A/en not_active Expired
- 1983-11-16 CH CH1315/86A patent/CH660010A5/en not_active IP Right Cessation
- 1983-11-17 FR FR8318293A patent/FR2536074B1/en not_active Expired
- 1983-11-17 BE BE0/211891A patent/BE898249A/en not_active IP Right Cessation
- 1983-11-17 NL NL8303955A patent/NL192792C/en not_active IP Right Cessation
- 1983-11-17 DE DE3347928A patent/DE3347928C2/de not_active Expired - Fee Related
- 1983-11-17 DE DE19833341591 patent/DE3341591A1/en active Granted
-
1985
- 1985-06-28 ES ES544723A patent/ES8607320A1/en not_active Expired
- 1985-06-28 ES ES544724A patent/ES8607321A1/en not_active Expired
- 1985-09-12 AU AU47421/85A patent/AU565648B2/en not_active Ceased
-
1986
- 1986-03-17 CA CA000504319A patent/CA1276139C/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8704955A1 (en) | New cephalosporin compounds and the production thereof. | |
ES8300112A1 (en) | their starting compounds and their preparation. | |
ES2000604A6 (en) | Process for the preparation of aryl-piperidine esters. | |
IE811580L (en) | Herbicidal compounds | |
CA2226406A1 (en) | Novel pyridone carboxylic acid derivatives | |
EP0268990A3 (en) | New benzothiadiazine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same | |
ES8607321A1 (en) | Cephalosporins | |
AU579116B2 (en) | Use of quinoline derivatives for the protection of cultivated plants | |
ES8301238A1 (en) | Dioxo piperazine compounds | |
MY103502A (en) | Novel compounds | |
DE3267188D1 (en) | Hydroxybenzylamino-aryl compounds, process for preparing and pharmaceutical compositions containing the same | |
IE811601L (en) | Pentapeptides | |
ES8305729A1 (en) | intermediates, useful in their preparation and a process for the preparation thereof. | |
ES8200113A1 (en) | Cephalosporin compounds | |
IE780262L (en) | Carbocyclic fused thiophen-2-oxaminic acid derivatives | |
ES8304973A1 (en) | Beta-lactam antibiotics, their preparation and use. | |
ES8608500A1 (en) | 1,2,4-Thiadiazines and their salts, process and intermediates for their preparation, their use as medicines and compositions containing them. | |
ES2010225A6 (en) | 2,6-Piperazine-dione derivatives, processes for their preparation and pharmaceutical compositions containing them. | |
JPS54106491A (en) | Cephalosporin analog or its salt, their preparation, and prophylactics and remedies for microbisms consisting mainly of them | |
ES8705450A1 (en) | New 1-oxa-1-dethia-cephalosporin compounds and antibacterial agent comprising the same. | |
IE41804L (en) | Substituted but-2-enoanilides, herbicides | |
AU543835B2 (en) | N-phthalidyl-5-fluorouracil derivatives | |
JPS57163386A (en) | Cephalosporin derivative and its production | |
ES2001766A6 (en) | Substituted hydroxy-heterocyclyl-alkoxy phosphinyloxy trialkylaminium hydroxide inner salt oxides, processes for their preparation and their use as pharmaceuticals. | |
AU561149B2 (en) | Cardiotonic 4-semicarbazide quindyolines |